Maxim Group Upgrades Galmed Pharmaceuticals to Buy, Announces $4 Price Target
Galmed Pharmaceuticals Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pacira Pharmaceuticals (PCRX), Galmed Pharmaceuticals (GLMD) and Rani Therapeutics Holdings (RANI)
No Data
No Data